CMS on May 9 posted reimbursement rates for 114 new molecular diagnostic codes established by local Medicare contractors using the clinical lab fee schedule gap-filling method. (http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Gapfill-Pricing-Inquiries.html
). Labs developing and running molecular diagnostics have complained that the price-setting process has been unfair and overly opaque. (See...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?